Preprint · CC-BY
via OpenAlex
Nicotinamide Mononucleotide Versus Nicotinamide Riboside in The Protective Effects of Cisplatin-induced DNA Damage in HeLa Cells
Shuting Qiu, Yunheng Zhang, Shihan Shao, Yingying Zhang, Jie Yin, Xianrong Xu, Lei Yang, Yu Hong, Jun Jie Yang, Xiaohua Tan, Chunhong Di
Research Square · 2023
Abstract
Abstract Background Previous studies have shown that the nicotinamide adenine dinucleotide (NAD+) precursors, nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), protected against endogenously or exogenously induced DNA damage, however, whether the two compounds have the same or different efficacy against DNA damage is not clear. In the current study, we systematically compared the effects of NMN and NR on cisplatin-induced DNA damage in HeLa cells. Methods The viability of cisplatin treated HeLa cells with NMN or NR were tested by Trypan blue staining. NMN and NR were added in cells before or after exposed to cisplatin, respectively. Briefly, HeLa cells were pretreated with series doses of NMN or NR (0、0.625、1.25、2.5、5 and 10 mM) for 12 h, and then challenged with 10 µM of cisplatin for the following 12 h; or, HeLa cells were treated by 10 µM of cispaltin for 12 h, and then cultured in medium with 10mM NMN or NR, the cells were harvested at 0, 8, 16, 24 and 32 h later. The DNA damage were assessed by immunofluorescent against phosphor-H2AX (γH2AX) and alkaline comet assay. The intracellular nicotinamide adenine dinucleotide (NAD+) and reactive oxygen species (ROS) were determined by according kit. Results Both NMN and NR could rescued cisplatin-induced cell death in a dose-dependent manner comparably. NMN and NR pretreatment decreased γH2AX levels and shortened comet tail length in a dose-dependent manner, while NR pretreatment exhibiting stronger protective effects than NMN. Although the post-cisplatin administration of NMN and NR also exhibited a protective effect against DNA damage, there were no significant differences between the two compounds. In addition, both NMN and NR can reverse the cisplatin-induced decrease of NAD+ and the generation of ROS, also with no significant difference between them. Conclusion NR is more effective than NMN in maintaining DNA integrity in cisplatin-treated cells.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-3177159/v1
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Qiu, S., Zhang, Y., Shao, S., Zhang, Y., Yin, J., Xu, X., Yang, L., Hong, Y., Yang, J.J., Tan, X., & Di, C. (2023). Nicotinamide Mononucleotide Versus Nicotinamide Riboside in The Protective Effects of Cisplatin-induced DNA Damage in HeLa Cells. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-3177159/v1
Vancouver
Qiu S, Zhang Y, Shao S, Zhang Y, Yin J, Xu X, et al. Nicotinamide Mononucleotide Versus Nicotinamide Riboside in The Protective Effects of Cisplatin-induced DNA Damage in HeLa Cells. Research Square. 2023. doi:10.21203/rs.3.rs-3177159/v1.
BibTeX
@unpublished{shuting2023Nicoti,
title = {Nicotinamide Mononucleotide Versus Nicotinamide Riboside in The Protective Effects of Cisplatin-induced DNA Damage in HeLa Cells},
author = {Shuting Qiu and Yunheng Zhang and Shihan Shao and Yingying Zhang and Jie Yin and Xianrong Xu and Lei Yang and Yu Hong and Jun Jie Yang and Xiaohua Tan and Chunhong Di},
journal = {Research Square},
year = {2023},
doi = {10.21203/rs.3.rs-3177159/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biochemistry and Biophysics Reports 2024
Open access · CC-BY
Comparison of protective effects of nicotinamide mononucleotide and nicotinamide riboside on DNA damage induced by cisplatin in HeLa cells
Cancer Research 2025
Citation only
Abstract 2326: Nicotinamide adenine dinucleotide precursors delay pancreatic cancer initiation and progression by promoting DNA repair and improving mitochondrial function
The Journal of Biochemistry 2023
Open access · CC-BY
Klotho protects chromosomal DNA from radiation-induced damage
German High-Grade Non-Hodgkin's Lymphoma Study Group 2005
Open access · US-GOV
Randomized Study Comparing 4 and 6 Cycles of Chemotherapy With CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) at 21-day Intervals, Both With 6 Cycles of Immunotherapy With the Monoclonal Anti-CD20-Positive B-Cell Lymphoma Aged 18-60 Years Having no Risk Factor (Age-Adjusted IPI=0) and No Large Tumor Mass (Diameter <7,5cm) [FLYER 6-6-6-4 Study]
Biotechnology Journal 2024
Open access · CC-BY
Evaluation of NAD+ precursors for improved metabolism and productivity of antibody‐producing CHO cell
Current microbiology 2026
Citation only